Bladder cancer trials in Canada

In Canada 41 Also abroad 626

41 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Where
Calgary, Halifax, Montreal, Toronto, Vancouver
Age
18 years and over
People
350 worldwide
Run by
enGene, Inc.
See details and how to joinNCT04752722 · EU 2024-512900-20-00
Phase 2/3Taking people
Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
Where
Halifax, London, Montreal, Sherbrooke, Toronto, Vancouver, Winnipeg
Age
18 years and over
People
70
Run by
Peter Black
See details and how to joinNCT06124976
Phase 2/3Taking people
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Where
Edmonton, Montreal, Ottawa, Toronto
Age
18 years and over
People
470 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07106762
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
Montreal, Toronto
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
Phase 2Taking people
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Where
Calgary, Montreal, Sherbrooke, Vancouver, Winnipeg
Age
18 years and over
People
372 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04879329 · EU 2022-500030-28-01
Phase 3Taking people
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Where
Abbotsford British Columbia, Barrie, Calgary, Hamilton, Kingston, London, Mississauga, Montreal
Age
18 years and over
People
915 worldwide
Run by
AstraZeneca
See details and how to joinNCT07720284
Phase 2Taking people
Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer
Where
Québec
Age
18 years and over
People
95
Run by
Paul Toren
See details and how to joinNCT07420517
Phase 3Taking people
Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)
Where
Kingston, Montreal, Toronto, Vancouver
Age
18 years and over
People
540
Run by
Verity Pharmaceuticals Inc.
See details and how to joinNCT05037279
No phaseTaking people
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Where
Toronto
Age
18 years and over
People
8,000 worldwide
Run by
UMC Utrecht
See details and how to joinNCT04075305
Phase 2Taking people
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
Where
Halifax, Hamilton, London, Montreal, Toronto, Vancouver
Age
18 years and over
People
90 worldwide
Run by
Theralase® Technologies Inc.
See details and how to joinNCT03945162
No phaseTaking people
Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)
Where
Vancouver
Age
50 years to 75 years
People
200 worldwide
Run by
Tampere University Hospital
See details and how to joinNCT06218433
No phaseTaking people
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
Where
Vancouver
Age
18 years to 100 years
People
3,000 worldwide
Run by
Tampere University Hospital
See details and how to joinNCT06310759
No phaseNot yet taking people in Canada
Enhancing Patient Comfort and Reducing Anxiety During Flexible Cystoscopy and Bladder Instillation in Bladder Cancer Patients: A Randomized Controlled Trial and Observational Study
Where
London
Age
18 years and over
People
378
Run by
Western University, Canada
See details and how to joinNCT07204301
Phase 2/3Taking people
NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment
Where
Vancouver
Age
19 years and over
People
688
Run by
Peter Black
See details and how to joinNCT06537154
Phase 1/2Not yet taking people in Canada
A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.
Where
Kingston
Age
65 years and over
People
31
Run by
Queen's University
See details and how to joinNCT07064863
No phaseTaking people
A Feasibility Randomized Trial Evaluating Early vs Late Stent Removal Following Radical Cystectomy and Ileal Conduit Formation for Bladder Cancer
Where
London
Age
18 years and over
People
60
Run by
Western University, Canada
See details and how to joinNCT06595446